BALCOLTRA (Ethinyl Estradiol; Levonorgestrel) Patent Expiration, LOE Window & CMS Spending

BALCOLTRA (Ethinyl Estradiol; Levonorgestrel) by Avion: FDA Orange Book core substance LOE 2027-06-01, 25 AB generics, $0 2024 CMS Part D & Medicaid spend, and 4 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorAvion
FDA Application & PathwayN208612 (NDA)
Exclusivity / Cliff HorizonImmediate Cliff (2025-2027)
Core Active-Ingredient LOE Date2027-06-01
Last Listed Patent or Exclusivity Date2027-06-01
Orange Book Patents (*PED Extensions)1 patents (0 *PED)
Active AB-Rated Generic Competitors25
2024 CMS Total Public Spend$0
2024 Medicare Part D Spend$0
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)4 WAC filings (max 29.4% 2-yr change)